Table 3. HRs with 95% confidence intervals from univariate analysis: median survival according to individual prognostic factors and delay to surgical resection.

Characteristics	Median survival (months)	P-value	HR	95% CI
Delay (days)		0.0041
0–21	12.6		1
22–42	13.29		0.962	(0.726–1.274)
43–63	15.19		0.817	(0.607–1.074)
>64	19		0.654	(0.454–0.845)
Age (years)		0.04
<60	18.02		1
60–70	14.86		1.26	(1.017–1.558)
>70	13.61		1.305	(1.053–1.614)
Gender		0.354
Female	16.04		1
Male	15.29		1.093	(0.907–1.314)
Hospital type		0.926
UHs	16.04		1
DGHs	14.76		1.008	(0.849–1.197)
Tumour location		0.369
Upper+middle	12.56		1
Lower	15.19		0.862	(0.641–1.145)
OGJ	16.24		0.825	(0.614–1.080)
Histology		0.578
AC	15.52		1
SCC	14.93		1.057	(0.868–1.289)
Tumour grade		0.025
WD	23.54		1
MD	16.41		1.185	(0.871–1.588)
PD	12.76		1.437	(1.054–1.828)
LN status		<0.0001
LN –ve	29.6		1
LN +ve	12.76		2.268	(1.847–2.624)
Resection		<0.0001
R0	19.1		1
R1/2	9.86		2.324	(2.474–3.921)

Abbreviations: AC, adenocarcinoma; CI, confidence interval; DGH, district general hospital; HR, hazard ratio; LN, lymph node; OGJ, oesophagogastric junction; Prh, private hospital; SCC, squamous cell carcinoma; UH, university hospitals.

Significant P-values in bold.